Jiangsu Canlon Building Materials Co., Ltd. (300715.SZ)
CNY 7.18
(-1.64%)
CNY 7.18
(-1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 192.58 Million | 46.36 Million | -383.84 Million | -111.34 Million | -46.46 Million | -24.1 Million |
| Net Income | 22.63 Million | -161.25 Million | 71.31 Million | 278.55 Million | 135.44 Million | 65.1 Million |
| Depreciation & Amortization | 103.22 Million | 83.95 Million | 59.4 Million | 31.81 Million | 17.84 Million | 14.18 Million |
| Deferred income taxes | -40.51 Million | -39.53 Million | -37.96 Million | -12.73 Million | -6.66 Million | -2.01 Million |
| Stock-based compensation | - | 34.95 Million | 11.94 Million | 2.17 Million | 4.02 Million | 621.59 Thousand |
| Change in working capital | -113.52 Million | -134.3 Million | -834.67 Million | -533.45 Million | -261.6 Million | -127.03 Million |
| Other non-cash items | 540.73 Million | 257.97 Million | 320.1 Million | 111.74 Million | 61.84 Million | 23.64 Million |
| Investing Cash Flow | -180.94 Million | -644.95 Million | -1.36 Billion | -432.37 Million | -201.26 Million | -56.29 Million |
| Investments in PPE | -285.28 Million | -605.01 Million | -346.88 Million | -383.27 Million | -205.15 Million | -56.69 Million |
| Acquisitions | 1.07 Million | 5.44 Million | 418.83 Thousand | 2941.75 | - | -46.28 Thousand |
| Investment purchases | - | -14 Million | -12.4 Million | - | - | -60 Million |
| Sales/Maturities of investments | - | -5.44 Million | -418.83 Thousand | - | - | 60 Million |
| Other Investing Activities | 103.25 Million | -25.94 Million | -1 Billion | -49.09 Million | 3.88 Million | 446.24 Thousand |
| Financing Cash Flow | 211.2 Million | 671.69 Million | 1.62 Billion | 235.08 Million | 776.52 Million | 71.49 Million |
| Debt repayment | -172.83 Million | -1.73 Billion | -1.57 Billion | -744.72 Million | -371 Million | -225.18 Million |
| Dividends payments | -85.07 Million | -227.64 Million | -102.45 Million | -17.09 Million | -6.57 Million | -22.45 Million |
| Common Stock Repurchased | - | -155.42 Million | -1.54 Billion | - | -489.8 Million | - |
| Common Stock Issuance | - | 155.42 Million | 1.54 Billion | - | 489.8 Million | - |
| Other Financing Activities | 45.24 Million | 2.7 Billion | 3.36 Billion | 1.02 Billion | 1.16 Billion | 319.14 Million |
| Accounts receivables | -366.19 Million | -165.31 Million | -933.57 Million | -1.13 Billion | -395.74 Million | -193.07 Million |
| Accounts payables | 243.09 Million | -14.55 Million | 200.8 Million | 666.9 Million | 190.66 Million | 107.36 Million |
| Inventory | 9.57 Million | 85.1 Million | -63.93 Million | -48.4 Million | -49.86 Million | -39.3 Million |
| Other working capital | 202.57 Million | -39.53 Million | -37.96 Million | -12.73 Million | -6.66 Million | -87.72 Million |
| Cash at beginning of period | 1.62 Billion | 333.24 Million | 455.93 Million | 767.87 Million | 238.54 Million | 247.14 Million |
| Cash at end of period | 1.78 Billion | 411.06 Million | 333.24 Million | 455.93 Million | 767.87 Million | 238.54 Million |
| Capital Expenditure | -285.28 Million | -605.01 Million | -346.88 Million | -383.27 Million | -205.15 Million | -56.69 Million |
| Effect of forex changes on cash | 1.3 Million | 4.7 Million | -597 Thousand | -3.3 Million | 535.7 Thousand | 307.81 Thousand |
| Net cash flow / Change in cash | 166.59 Million | 77.82 Million | -122.69 Million | -311.93 Million | 529.32 Million | -8.59 Million |
| Free Cash Flow | -92.7 Million | -558.64 Million | -730.72 Million | -494.62 Million | -251.62 Million | -80.79 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -39.91 Million | -106.59 Thousand | 7.87 Million | 22.63 Million | -52.44 Million | 19.87 Million |
| Depreciation & Amortization | - | 32.39 Million | 32.39 Million | 103.22 Million | 29.22 Million | 29.22 Million |
| Deferred income taxes | - | - | - | -40.51 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -244.24 Million | - | -113.52 Million | -356.61 Million | 368.16 Million |
| Other non-cash items | -166.82 Million | -14.05 Million | -268.45 Million | 540.73 Million | 548.27 Million | -327.65 Million |
| Investing Cash Flow | -48.6 Million | 316.51 Million | -61.12 Million | -180.94 Million | -64.77 Million | -33.12 Million |
| Investments in PPE | -49.93 Million | -32.6 Million | -61.27 Million | -285.28 Million | -55.88 Million | -44.97 Million |
| Acquisitions | 179.46 Thousand | 430 Thousand | 157.5 Thousand | 1.07 Million | 825.14 Thousand | 249 Thousand |
| Investment purchases | - | - | -30 Million | - | - | 10 Million |
| Sales/Maturities of investments | - | - | 30 Million | - | - | -10.24 Million |
| Other Investing Activities | 1.32 Million | -599.99 Million | -6000.00 | 103.25 Million | -9.7 Million | 11.85 Million |
| Financing Cash Flow | 84 Million | -178.87 Million | -155.45 Million | 211.2 Million | -227.1 Million | 261.65 Million |
| Debt repayment | -76.98 Million | -242.72 Million | -6.23 Million | -172.83 Million | -504.67 Million | -125.5 Million |
| Dividends payments | -15.42 Million | -75.68 Million | -21.27 Million | -85.07 Million | -18.24 Million | -21.41 Million |
| Common Stock Repurchased | - | -700 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 176.4 Million | -418.67 Million | -161.68 Million | 45.24 Million | 284.44 Million | 408.56 Million |
| Accounts receivables | - | -176.51 Million | - | -366.19 Million | -366.19 Million | 305.52 Million |
| Accounts payables | - | - | - | 243.09 Million | - | - |
| Inventory | - | -67.72 Million | - | 9.57 Million | 9.57 Million | 62.64 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 250.44 Million | 1.33 Billion | 1.78 Billion | 1.62 Billion | 1.5 Billion | 429 Million |
| Cash at end of period | 79.39 Million | 1.33 Billion | 1.33 Billion | 1.78 Billion | 1.78 Billion | 460.87 Million |
| Capital Expenditure | -49.93 Million | -32.6 Million | -61.27 Million | -285.28 Million | -55.88 Million | -44.97 Million |
| Effect of forex changes on cash | 72.87 Thousand | 1.27 Million | 76.13 Thousand | 1.3 Million | -409.35 Thousand | -242.94 Thousand |
| Net cash flow / Change in cash | -171.05 Million | -2.58 Million | -453.86 Million | 166.59 Million | 286.81 Million | 31.87 Million |
| Free Cash Flow | -256.67 Million | -79.16 Million | -321.86 Million | -92.7 Million | 410.72 Million | -352.75 Million |
3027
BIOA-B
0IPB
DTR
BLFY
300124